High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma.
about
HMGA2 exhibits dRP/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapyMicroRNA-210: a unique and pleiotropic hypoxamirMicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancerThe let-7 microRNA interfaces extensively with the translation machinery to regulate cell differentiationLow-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinomaRepression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosisSuppression of non-small cell lung tumor development by the let-7 microRNA familyLet-7 and miR-200 microRNAs: guardians against pluripotency and cancer progressionFrequent overexpression of HMGA1 and 2 in gastroenteropancreatic neuroendocrine tumours and its relationship to let-7 downregulationThe tumor suppressor microRNA let-7 represses the HMGA2 oncogene.The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosisTargeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressivenessHypoxamiRs and cancer: from biology to targeted therapyOxymiRs in cutaneous development, wound repair and regenerationHMGA1-pseudogenes and cancerLet-7 repression leads to HMGA2 overexpression in uterine leiomyosarcomaLung cancer epigenetics: emerging biomarkersOverexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomasEnvironmental chemical exposures and human epigeneticsTelomere shortening sensitizes cancer cells to selected cytotoxic agents: in vitro and in vivo studies and putative mechanismsA systems biology approach to characterize the regulatory networks leading to trabectedin resistance in an in vitro model of myxoid liposarcomaMicroRNAs in cancer.Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis.microRNA evaluation of unknown primary lesions in the head and neckThe VHL-dependent regulation of microRNAs in renal cancer.MicroRNA-146b promotes myogenic differentiation and modulates multiple gene targets in muscle cells.Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxiaTargeted regulation of MiR-98 on E2F1 increases chemosensitivity of leukemia cells K562/A02.microRNAs and lung cancer: tumors and 22-mers.MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines.Upregulation of TRB2 induced by miR-98 in the early lesions of large artery of type-2 diabetic rat.Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neckIdentification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinomaThioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7Polypyrimidine tract binding protein (hnRNP I) is possibly a conserved modulator of miRNA-mediated gene regulationThe Caenorhabditis elegans SOMI-1 zinc finger protein and SWI/SNF promote regulation of development by the mir-84 microRNA.Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis.MicroRNA-24 targeting RNA-binding protein DND1 in tongue squamous cell carcinoma.MicroRNA-27a promotes proliferation and suppresses apoptosis by targeting PLK2 in laryngeal carcinoma
P2860
Q24313419-A89F374C-9B36-4593-8EAF-E00DC3AC2434Q24601095-C9422C96-9720-4E82-9931-C3C8249D7093Q24607952-1FAC40C2-72DB-4D82-8FCC-2280B781045CQ24630894-0C037B93-A51A-4C37-B61D-FC9D59A6687FQ24633246-3A16A4EC-40A6-4949-8D1E-2A57892DA801Q24646667-B3AD9636-6CA3-4ABB-9AE4-CB6E37E2659DQ24648286-56AA40F4-A70A-4CE0-9B98-B7B79D5116E6Q24651985-4A3E608F-C3C9-4C65-832F-5F5F57E71E0CQ24653755-57EFA49B-58BB-483B-AB02-AD067A075D10Q24655168-881B811C-5400-473A-B2DA-4E9EA15246D9Q24681392-10B493A5-3557-4161-A304-A01DCE6E80F0Q26797382-8E31441B-62C7-4320-9212-E4CD85CEBC8EQ26822776-2C515543-A893-481F-8DA2-A8EF1780D8ECQ26863298-86104935-2E23-488A-B8D6-D80EAA04DF84Q27024906-EF7DF933-FF8F-4B5E-AEFA-DFB3A5CB5468Q28072498-374DC0DA-5885-4247-9D25-9EF6373CDD95Q28251930-DA21393A-A7A5-4A35-95A6-CA72CB477B48Q28285049-74288469-DDA5-48E0-BCB8-7524725FAC20Q28306491-5D2DD06A-25E3-42CC-8786-223A6B9303DEQ28397621-C750B6CB-775B-49CA-A929-DB82EEED875DQ28472826-F4F1AD25-AAC5-4525-9918-EBFF60973823Q28482357-559C228F-639E-4B72-9F99-1590E1111BDAQ30437444-744E6D67-A4CA-46FE-913A-FA752F6D6DAAQ33367473-4CA8B5B8-5F32-496B-8333-A4464C9A9B7FQ33592209-F88928B2-F836-4B25-9D4B-5EDDA82C9ED9Q33724729-049953BD-306C-4347-9C36-333677AFC5AFQ33793637-AED6DF2D-0A5C-41E5-8DE5-9FF351A40F4BQ33798508-459FCCFB-096B-4611-904A-219508C9CDEAQ33879017-1AFC479A-7F42-4E97-AC8B-D4B0C14038B3Q33910328-0957AB54-A97F-4071-ADA5-512DAEA3E430Q33932172-E1FCD469-CFBF-4D00-9186-47BC0F14E45BQ34052066-43A4ADDD-A466-4A38-9F2C-5BEA30D88242Q34120872-73E84B66-8395-4749-9938-79D426086868Q34150057-FBE7A978-0625-4244-8AAB-B59468F34112Q34156481-F8D782C1-9536-4F12-B1B8-BA75E578FE74Q34200537-9B3CF343-D545-4352-A986-93DB00BA75E0Q34222089-2321B771-F06F-4174-8D2C-F29AD6D94F7AQ34237969-29656DA1-F358-486A-A316-D99352F5E10AQ34245134-EB44E444-12AD-4491-B9A2-3FEFEAC9A0ADQ34253848-73E611AC-A1F1-4E16-BD9B-318F649B1D1E
P2860
High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma.
@en
type
label
High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma.
@en
prefLabel
High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma.
@en
P2093
P2860
P356
P1433
P1476
High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma.
@en
P2093
Carla Hebert
John J Sauk
Kathleen Norris
Mark A Scheper
Nikolaos Nikitakis
P2860
P2888
P356
10.1186/1476-4598-6-5
P577
2007-01-14T00:00:00Z
P5875
P6179
1031769576